Literature DB >> 24440553

Transferring inpatient rehabilitation facility cancer patients back to acute care (TRIPBAC).

Arash Asher1, Pamela S Roberts2, Catherine Bresee3, Garret Zabel4, Richard V Riggs5, Andre Rogatko6.   

Abstract

OBJECTIVE: To determine predictive factors for TRansferring Inpatient rehabilitation facility (IRF) cancer Patients Back to Acute Care (TRIPBAC).
DESIGN: A retrospective chart review of patients with cancer admitted to an IRF from 2009 to 2010 because of a functional impairment that developed as a direct consequence of their cancer or its treatment.
SETTING: IRF of a community-based, academic, tertiary care facility.
METHODS: The characterization of patients with cancer in the IRF was primarily based on analysis of the IRF Patient Assessment Instrument and other internal IRF data logs. MAIN OUTCOME MEASUREMENT: Frequency and reasons for TRIPBAC.
RESULTS: The TRIPBAC rate in our IRF was 17.4%. The most common reasons for TRIPBAC were postneurosurgical complications (31%). Factors associated with TRIPBAC were a motor Functional Independence Measure score of 35 points or lower on admission (odds ratio 4.01, 95% confidence interval 1.79-8.98; P = .001) and the presence of a feeding tube or a modified diet (odds ratio 3.18, 95% confidence interval 1.44-7.04; P = .004).
CONCLUSIONS: Motor Functional Independence Measure score on admission is the best predictor for TRIPBAC in patients with cancer admitted to our IRF, followed by the presence of a feeding tube or a modified diet.
Copyright © 2014 American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24440553     DOI: 10.1016/j.pmrj.2014.01.009

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


  8 in total

Review 1.  A Guide to Inpatient Cancer Rehabilitation: Focusing on Patient Selection and Evidence-Based Outcomes.

Authors:  Jack B Fu; Vishwa S Raj; Ying Guo
Journal:  PM R       Date:  2017-09       Impact factor: 2.298

2.  Inpatient Rehabilitation Delirium Screening: Impact on Acute Care Transfers and Functional Outcomes.

Authors:  Sharon Bushi; A M Barrett; Mooyeon Oh-Park
Journal:  PM R       Date:  2020-01-16       Impact factor: 2.298

3.  Predictors of readmission to acute care during inpatient rehabilitation for non-traumatic spinal cord injury.

Authors:  David M Robinson; Moussa S Bazzi; Scott R Millis; Ali A Bitar
Journal:  J Spinal Cord Med       Date:  2018-01-22       Impact factor: 1.985

4.  Characterization of Cancer Patients in Inpatient Rehabilitation Facilities: A Retrospective Cohort Study.

Authors:  Jacqueline M Mix; Carl V Granger; Michael J LaMonte; Paulette Niewczyk; Margaret A DiVita; Richard Goldstein; Jerome W Yates; Jo L Freudenheim
Journal:  Arch Phys Med Rehabil       Date:  2017-02-01       Impact factor: 3.966

5.  Functional Status Outperforms Comorbidities in Predicting Acute Care Readmissions in Medically Complex Patients.

Authors:  Shirley L Shih; Paul Gerrard; Richard Goldstein; Jacqueline Mix; Colleen M Ryan; Paulette Niewczyk; Lewis Kazis; Jaye Hefner; D Clay Ackerly; Ross Zafonte; Jeffrey C Schneider
Journal:  J Gen Intern Med       Date:  2015-05-09       Impact factor: 5.128

6.  Predictors of Acute Transfer and Mortality Within 6 Months From Admission to an Inpatient Rehabilitation Facility for Patients With Brain Tumors.

Authors:  Sasha E Knowlton; Alexandra I Gundersen; Julia M Reilly; Can Ozan Tan; Jeffrey C Schneider; Shirley L Shih
Journal:  Arch Phys Med Rehabil       Date:  2021-11-09       Impact factor: 4.060

7.  Factors associated with unplanned transfers among cancer patients at a freestanding acute rehabilitation facility.

Authors:  Akash Bhakta; Ishan Roy; Kevin Huang; Jacqueline Spangenberg; Prakash Jayabalan
Journal:  PM R       Date:  2021-09-01       Impact factor: 2.218

8.  Medical Complications and Prognostic Factors for Medically Unstable Conditions During Acute Inpatient Cancer Rehabilitation.

Authors:  Jegy M Tennison; Brian C Fricke; Jack B Fu; Tejal A Patel; Minxing Chen; Eduardo Bruera
Journal:  JCO Oncol Pract       Date:  2021-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.